Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | TEAD3 | Q99594 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | AGXT | P21549 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL101220 | 0.91 | L3MBTL1 (0.53) | TSHRNAAAALOX15L3MBTL1TEAD3 | |
| SCHEMBL149658 | 0.90 | TSHR (0.61) | TSHRALOX15L3MBTL1TEAD3CA1 | |
| SCHEMBL20953940 | 0.90 | TSHR (0.61) | TSHRALOX15L3MBTL1TEAD3CA1 | |
| SCHEMBL5035399 | 0.88 | TSHR (0.58) | TSHRALOX15L3MBTL1TEAD3CA1 | |
| Ammonia Solution, Strong SCHEMBL27983434 | 0.88 | TSHR (0.58) | TSHRALOX15L3MBTL1TEAD3CA1 | |
| Adipic Acid SCHEMBL4790742 | 0.86 | L3MBTL1 (0.47) | TSHRL3MBTL1TEAD3MAPTHTT | |
| SCHEMBL11103994 | 0.85 | TSHR (0.47) | TSHRNAAAALOX15L3MBTL1TEAD3 | |
| Adipic Acid SCHEMBL17022706 | 0.84 | L3MBTL1 (0.46) | L3MBTL1TEAD3MAPTHTTSMN1; SMN2 | |
| SCHEMBL321275 | 0.83 | LMNA (0.51) | L3MBTL1MAPTLTA4HSMN1; SMN2KDM4E | |
| SCHEMBL1991359 | 0.82 | TSHR (0.78) | TSHRNAAAL3MBTL1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798564-A | Photopolymer holographic recording medium, grating, preparation method and equipment thereof | 珠海莫界科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119798564-A | Photopolymer holographic recording medium, grating, preparation method and equipment thereof | 珠海莫界科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| WO-2024249235-A1 | ANTI-HUMAN CD33 BET DEGRADER ANTIBODY-DRUG CONJUGATES | ABBVIE INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| CN-108976278-B | Chimeric molecule and preparation and application thereof | 海创药业股份有限公司 | 2021-04-06 | — | — | CN | disclosed |
| EP-1756135-B1 | ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS | GLAXOSMITHKLINE ZAGREB (HR) | 2009-08-12 | — | — | EP | disclosed |
| EP-1756135-B1 | ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS | GLAXOSMITHKLINE ZAGREB (HR) | 2009-08-12 | — | — | EP | disclosed |
| US-20080255060-A1 | Ester Linked Macrolides Useful For The Treatment of Microbial Infections | GLAXOSMITHKLINE ISTRAZIVACKI CENTER ZAGREB (HR) | 2008-10-16 | — | — | US | disclosed |
| CN-101068824-A | Ester-linked macrolides for the treatment of microbial infections | GLAXOSMITHKLINE ZAGREB (HR) | 2007-11-07 | — | — | CN | disclosed |
| EP-1756135-A1 | ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS | GlaxoSmithKline istrazivacki centar Zagreb d.o.o. (HR) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005108412-A1 | ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS | GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (US) | 2005-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255060-A1 | Ester Linked Macrolides Useful For The Treatment of Microbial Infections | CYP51A1, TLR5, MALT1 | TSHR 2881/4885NAAA 842/4885ALOX15 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.